• Home
  • Pharmaceuticals and Healthcare
PD-L1 and PIK3CA Testing Market - Global Outlook and Forecast 2021-2027

PD-L1 and PIK3CA Testing Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ878905 | No. of Pages: 94 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Aug-2021 
This report contains market size and forecasts of PD-L1 and PIK3CA Testing in Global, including the following market information:
Global PD-L1 and PIK3CA Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global PD-L1 and PIK3CA Testing market was valued at 417.2 million in 2020 and is projected to reach US$ 856.8 million by 2027, at a CAGR of 19.7% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PD-L1 and PIK3CA Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PD-L1 and PIK3CA Testing Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global PD-L1 and PIK3CA Testing Market Segment Percentages, By Type, 2020 (%)
    PD-L1 Testing
    PIK3CA Testing

China PD-L1 and PIK3CA Testing Market, By Application, 2016-2021, 2022-2027 ($ millions)
China PD-L1 and PIK3CA Testing Market Segment Percentages, By Application, 2020 (%)
    Hospital
    Diagnostic Center
    Others

Global PD-L1 and PIK3CA Testing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global PD-L1 and PIK3CA Testing Market Segment Percentages, By Region and Country, 2020 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total PD-L1 and PIK3CA Testing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total PD-L1 and PIK3CA Testing Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
    Agilent Technologies
    Roche
    QIAGEN
    EntroGen
    Amoy Diagnostics
    ACCB Biotech
1 Introduction to Research & Analysis Reports
    1.1 PD-L1 and PIK3CA Testing Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global PD-L1 and PIK3CA Testing Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global PD-L1 and PIK3CA Testing Overall Market Size
    2.1 Global PD-L1 and PIK3CA Testing Market Size: 2021 VS 2027
    2.2 Global PD-L1 and PIK3CA Testing Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top PD-L1 and PIK3CA Testing Players in Global Market
    3.2 Top Global PD-L1 and PIK3CA Testing Companies Ranked by Revenue
    3.3 Global PD-L1 and PIK3CA Testing Revenue by Companies
    3.4 Top 3 and Top 5 PD-L1 and PIK3CA Testing Companies in Global Market, by Revenue in 2020
    3.5 Global Companies PD-L1 and PIK3CA Testing Product Type
    3.6 Tier 1, Tier 2 and Tier 3 PD-L1 and PIK3CA Testing Players in Global Market
        3.6.1 List of Global Tier 1 PD-L1 and PIK3CA Testing Companies
        3.6.2 List of Global Tier 2 and Tier 3 PD-L1 and PIK3CA Testing Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global PD-L1 and PIK3CA Testing Market Size Markets, 2021 & 2027
        4.1.2 PD-L1 Testing
        4.1.3 PIK3CA Testing
    4.2 By Type - Global PD-L1 and PIK3CA Testing Revenue & Forecasts
        4.2.1 By Type - Global PD-L1 and PIK3CA Testing Revenue, 2016-2021
        4.2.2 By Type - Global PD-L1 and PIK3CA Testing Revenue, 2022-2027
        4.2.3 By Type - Global PD-L1 and PIK3CA Testing Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global PD-L1 and PIK3CA Testing Market Size, 2021 & 2027
        5.1.2 Hospital
        5.1.3 Diagnostic Center
        5.1.4 Others
    5.2 By Application - Global PD-L1 and PIK3CA Testing Revenue & Forecasts
        5.2.1 By Application - Global PD-L1 and PIK3CA Testing Revenue, 2016-2021
        5.2.2 By Application - Global PD-L1 and PIK3CA Testing Revenue, 2022-2027
        5.2.3 By Application - Global PD-L1 and PIK3CA Testing Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global PD-L1 and PIK3CA Testing Market Size, 2021 & 2027
    6.2 By Region - Global PD-L1 and PIK3CA Testing Revenue & Forecasts
        6.2.1 By Region - Global PD-L1 and PIK3CA Testing Revenue, 2016-2021
        6.2.2 By Region - Global PD-L1 and PIK3CA Testing Revenue, 2022-2027
        6.2.3 By Region - Global PD-L1 and PIK3CA Testing Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America PD-L1 and PIK3CA Testing Revenue, 2016-2027
        6.3.2 US PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.3.3 Canada PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.3.4 Mexico PD-L1 and PIK3CA Testing Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe PD-L1 and PIK3CA Testing Revenue, 2016-2027
        6.4.2 Germany PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.4.3 France PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.4.4 U.K. PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.4.5 Italy PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.4.6 Russia PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.4.7 Nordic Countries PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.4.8 Benelux PD-L1 and PIK3CA Testing Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia PD-L1 and PIK3CA Testing Revenue, 2016-2027
        6.5.2 China PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.5.3 Japan PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.5.4 South Korea PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.5.5 Southeast Asia PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.5.6 India PD-L1 and PIK3CA Testing Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America PD-L1 and PIK3CA Testing Revenue, 2016-2027
        6.6.2 Brazil PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.6.3 Argentina PD-L1 and PIK3CA Testing Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa PD-L1 and PIK3CA Testing Revenue, 2016-2027
        6.7.2 Turkey PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.7.3 Israel PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.7.4 Saudi Arabia PD-L1 and PIK3CA Testing Market Size, 2016-2027
        6.7.5 UAE PD-L1 and PIK3CA Testing Market Size, 2016-2027
7 Players Profiles
    7.1 Agilent Technologies
        7.1.1 Agilent Technologies Corporate Summary
        7.1.2 Agilent Technologies Business Overview
        7.1.3 Agilent Technologies PD-L1 and PIK3CA Testing Major Product Offerings
        7.1.4 Agilent Technologies PD-L1 and PIK3CA Testing Revenue in Global (2016-2021)
        7.1.5 Agilent Technologies Key News
    7.2 Roche
        7.2.1 Roche Corporate Summary
        7.2.2 Roche Business Overview
        7.2.3 Roche PD-L1 and PIK3CA Testing Major Product Offerings
        7.2.4 Roche PD-L1 and PIK3CA Testing Revenue in Global (2016-2021)
        7.2.5 Roche Key News
    7.3 QIAGEN
        7.3.1 QIAGEN Corporate Summary
        7.3.2 QIAGEN Business Overview
        7.3.3 QIAGEN PD-L1 and PIK3CA Testing Major Product Offerings
        7.3.4 QIAGEN PD-L1 and PIK3CA Testing Revenue in Global (2016-2021)
        7.3.5 QIAGEN Key News
    7.4 EntroGen
        7.4.1 EntroGen Corporate Summary
        7.4.2 EntroGen Business Overview
        7.4.3 EntroGen PD-L1 and PIK3CA Testing Major Product Offerings
        7.4.4 EntroGen PD-L1 and PIK3CA Testing Revenue in Global (2016-2021)
        7.4.5 EntroGen Key News
    7.5 Amoy Diagnostics
        7.5.1 Amoy Diagnostics Corporate Summary
        7.5.2 Amoy Diagnostics Business Overview
        7.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Major Product Offerings
        7.5.4 Amoy Diagnostics PD-L1 and PIK3CA Testing Revenue in Global (2016-2021)
        7.5.5 Amoy Diagnostics Key News
    7.6 ACCB Biotech
        7.6.1 ACCB Biotech Corporate Summary
        7.6.2 ACCB Biotech Business Overview
        7.6.3 ACCB Biotech PD-L1 and PIK3CA Testing Major Product Offerings
        7.6.4 ACCB Biotech PD-L1 and PIK3CA Testing Revenue in Global (2016-2021)
        7.6.5 ACCB Biotech Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com